Innovative Journal of Pediatrics
The Scientific Journal of Growth & Development Research Center
Outline
Combination of Probiotics and Antibiotics in the Prevention of Recurrent Urinary Tract Infection in Children
Authors
Abstract
Objective: We examined the preventive effect of probiotic and antibiotics versus antibiotics alone, in children with recurrent urinary tract infections (RUTI) in a preliminary randomized clinical trial. Methods: Between March 2007 and April 2011, children with the history of RUTI and unilateral vesicoureteral reflux (VUR) were randomly assigned to receive concomitant probiotic and antibiotics (Lactobacillus acidophilus and bifidobacterium lactis, 107/ml, as 0.25 ml/kg three times a day regimen in addition to Nitrofurantoin, 1mg/kg daily (group I). In group II, all children received conventional prophylactic antibiotics alone (Nitrofurantoin, 1 mg/kg daily). Randomization was performed via using the random numerals table in a 1:1 manner with stratification by sex, age and grade of reflux. The urine examinations were done monthly and the incidence of UTI was evaluated in these two groups. Findings: Forty-one children (age: 8.3±3.1 years) in group I and 44 children (age: 8.0±3.0 years) in group II were compared. During the course of three years, 39% in group I and 50% of participants in group II experienced RUTIs (P=0.4). Incidences of UTI - febrile and afebrile - reduced in both groups without any significant differences after two years of prophylaxis. Also, incidence of afebrile UTIs did not significantly differ (0.51±1.30 and 0.81±1.41 respectively, P=0.3); however, the incidence of febrile UTIs in particular were lower in group I (0.00±0.00 versus 0.13±0.40, P=0.03) in the last year. Conclusion: The consumption of probiotic and antibiotics in children with RUTI is safe and more effective in reducing the incidence of febrile UTI in comparison to prophylactic antibiotics alone.
References
- 1.References are available on the PDF.
Copyright
© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Probiotics for Prophylaxis and Treatment of Urinary Tract Infections in Children
Beyitler I, Kavukcu S. Probiotics for Prophylaxis and Treatment of Urinary Tract Infections in Children. Inn J Pediatr. 2017;27(2):e7695. doi: https://doi.org/10.5812/ijp.7695
Daily vs. Every-Other-Day Antibiotic Prophylaxis in Children with Vesicoureteral Reflux: A Randomized Clinical Trial
Malakuti N, Mohajeri S, Raeisi Shahraki H, Salehifardjouneghani A. Daily vs. Every-Other-Day Antibiotic Prophylaxis in Children with Vesicoureteral Reflux: A Randomized Clinical Trial. Jundishapur J Nat Pharm Prod. 2025;20(4):e165012. doi: https://doi.org/10.5812/jjnpp-165012
Prevalence of Vesicoureteral Reflux and Urinary Tract Infection in Children with and without Urolithiasis
Yousefichaijan P, Safi F, Rezagholizamenjany M, Safari M, Shariatmadari F. Prevalence of Vesicoureteral Reflux and Urinary Tract Infection in Children with and without Urolithiasis. Nephro-Urol Mon. 2020;12(4):e103276. doi: https://doi.org/10.5812/numonthly.103276
A Comparison Between Bacterial Resistance to Common Antibiotics in Breast-Fed and Bottle-Fed Female Infants With Urinary Tract Infection
Yousefi Chaijan P, Sharafkhah M. A Comparison Between Bacterial Resistance to Common Antibiotics in Breast-Fed and Bottle-Fed Female Infants With Urinary Tract Infection. Arch Clin Infect Dis. 2012;7(4):113-5. doi: https://doi.org/10.5812/archcid.15090
Efficacy of Ascorbic Acid Supplementation in Relief of Symptoms Due to Febrile Upper Urinary Tract Infection in Children, a Clinical Trial and Hospital Based Study
Yousefichaijan P, Ahmad Goudarzi A, Rezagholizamenjany M, Kahbazi M, Rafeie M, et al. Efficacy of Ascorbic Acid Supplementation in Relief of Symptoms Due to Febrile Upper Urinary Tract Infection in Children, a Clinical Trial and Hospital Based Study. Arch Pediatr Infect Dis. 2018;6(4):e57071. doi: https://doi.org/10.5812/pedinfect.57071
- Scopus by DOI: 0
Last Update: 3 weeks ago
- Scopus by Title: 50
Last Update: 3 weeks ago
- Scopus by Title (Ref): 50
Last Update: 3 weeks ago
- CrossRef: 0
Last Update: 3 days ago